The pattern no single source sees

Search

Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.

Company or person28

Theriva Biologics, Inc.

Company

3 records in the corpus

HCW Biologics Inc.

Company

10 records in the corpus

ADMA BIOLOGICS, INC.

Company

4 records in the corpus

AbCellera Biologics Inc.

Company

9 records in the corpus

FibroBiologics, Inc.

Company

6 records in the corpus

BioXcel Therapeutics, Inc.

Company

7 records in the corpus

Artiva Biotherapeutics, Inc.

Company

41 records in the corpus

Bicara Therapeutics Inc.

Company

9 records in the corpus

Beam Therapeutics Inc.

Company

8 records in the corpus

THC Therapeutics, Inc.

Company

1 records in the corpus

Bone Biologics Corp

Company

8 records in the corpus

BridgeBio Oncology Therapeutics, Inc.

Company

9 records in the corpus

Serina Therapeutics, Inc.

Company

6 records in the corpus

SAB Biotherapeutics, Inc.

Company

5 records in the corpus

Bolt Biotherapeutics, Inc.

Company

9 records in the corpus

C4 Therapeutics, Inc.

Company

10 records in the corpus

Beta Bionics, Inc.

Company

21 records in the corpus

Bambusa Therapeutics, Inc.

Company

11 records in the corpus

Theravance Biopharma, Inc.

Company

24 records in the corpus

Cardiol Therapeutics Inc.

Company

2 records in the corpus

Acrivon Therapeutics, Inc.

Company

12 records in the corpus

BioStem Technologies, Inc.

Company

24 records in the corpus

AN2 Therapeutics, Inc.

Company

12 records in the corpus

PTC THERAPEUTICS, INC.

Company

15 records in the corpus

Nuo Therapeutics, Inc.

Company

4 records in the corpus

vTv Therapeutics Inc.

Company

2 records in the corpus

Turn Therapeutics Inc.

Company

7 records in the corpus

Vera Therapeutics, Inc.

Company

4 records in the corpus

Primary record2

Theriva Biologics, Inc. filed 8-K

Item 1.01. Entry into a Material Definitive Agreement. On October 30, 2026 (the “Effective Date”), Theriva Biologics, Inc. (the “Company”) entered into an Asset Purchase and Sale Agreement (the “Purchase Agreement”) with

02 Nov 2026 · sec daily index

Theriva Biologics, Inc. filed DEF 14A

SEC form DEF 14A filed by Theriva Biologics, Inc. (CIK 894158) on 2026-10-20.

20 Oct 2026 · sec daily index